Pharmacoepidemiology and Drug Safety

Article	Citations
	96
Issue Information	66
Letter to the Editor	51
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer	49
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research	38
External validity in distributed data networks	36
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”	34
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries	33
Issue Information	32
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018	32
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis	31
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark	31
Issue Information	31
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review	25
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries	25
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data	22
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review	22
ORAL PRESENTATION	21
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+	21
Issue Information	20
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems	20
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	20
Data Resource Profile: The Danish National Hospital Medicine Register	20
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study	19
	19

Comorbidity influence in observational studies: Why ignore the real world?	18
Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records	18
Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions	18
Advancing Research Transparency and Reproducibility in Pharmacoepidemiology	17
Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis	17
Trends in the Dispensing of Oral Anti‐Cancer Medications Across Australia Over 10 Years	16
	15
Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years	15
	15
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases	14
Valproate utilisation trends among women of childbearing potential in Ireland between 2014 and 2019: A drug utilisation study using interrupted time series	14
Corrigendum to “A Brief Report on Proposed Areas of International Harmonization of Real‐World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators”	14
Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databases	13
Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade	13
Overlap Weights for Binary Outcomes: A Performance Assessment	13
Validity of ICD‐10‐based algorithms to identify patients with influenza in inpatient and outpatient settings	13
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe	13
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke	12
An individual segmented trajectory approach for identifying opioid use patterns using longitudinal dispensing data	12
Issue Information	12
An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer	12
Validation of alopecia coding in US claims data among women of childbearing age	12
Federated analyses of multiple data sources in drug safety studies	12
Probabilistic precision calculations for the planning of studies assessing negative binomial rates	12
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis	12
Hypertension medication from guidelines to practice: A cohort study in western Iran	12
Impact of Lookback Duration on the Performance of a Claims‐Based Frailty Proxy in Women With Stage I–III Breast Cancer	12
Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real‐world data source on medication use in pregnancy in Belgium	12
Hazard Ratios and Alternative Effect Measures: An Applied Illustration	12
Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review	12
The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population	11
Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation	11
Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community	11
Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids	11
The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths	11
Issue Information	11
Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management	11
Issue Information	11
Clozapine‐Associated Neutropenia Prevalence in a Large, Integrated Healthcare System	11
Validation of an algorithm to identify fractures among patients within the Veterans Health Administration	11
Review of Mother–Infant Linkage Algorithms in Health Care Data Sources	11
The risk of miscarriage after COVID‐19 vaccination before and during pregnancy	10
10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology	10
Issue Information	10
Assessing medical product safety during pregnancy using parameterizable tools in the sentinel distributed database	10
Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus	10
Glucagon‐like Peptide‐1 Receptor Agonists in Asthma Exacerbations: An Application of High‐Dimensional Iterative Causal Forest to Identify Subgroups	10
Consistency between the National Patient Register and the Swedish Cancer Register	10
Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID‐19 patients in Japan	10
Characterization of SARS‐CoV‐2 Diagnostic Tests and Liver Function Tests Among Patients With COVID‐19 Diagnosed in Outpatient Settings Using Administrative Healthcare	10

Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe	10
Issue Information	10
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned	9
Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large‐scale COVID‐19 surveillance system	9
Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations	9
Valproic Acid‐Induced Congenital Disorders, an Analysis in EudraVigilance and a Literature Review of Valproic Acid Utilization During Pregnancy	9
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications	9
Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong	9
ABSTRACTS of the 2024 ISPE Annual Meeting, Berlin, Germany, 24–28 August 2024	8
Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists (GLP‐1‐RAs) in Type 2 Diabetes and Chronic Weight Management: A Real‐World Data Study	8
Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes	8
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies	8
A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients	8
Trends in clomiphene citrate and gonadotropins use in women with infertility between 2010 and 2017: A population‐based study in France	8
Association of Quinolone Exposure in the First‐Trimester of Pregnancy and the Risk of Major Congenital Malformations: A Health Administrative Database Study in Japan	8
Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries	8
A drug utilization study of thiocolchicoside‐containing medicinal products for systemic use in France and Italy: A cross‐sectional electronic medical records database study	8
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System	8
Issue Information	8
Effectiveness and Safety of Reduced and Standard Initial Doses of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study in Taiwan	8
ISPE20 Author Index	8
Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta‐Analysis	7
RE: Gout and sodium‐glucose cotransporter‐2 inhibitors	7
Detecting and Dating Early Non‐live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries	7
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 3	7
	7
	7
Comparison of record linkage software for deduplicating patient identities in California's Prescription Drug Monitoring Program	7
TriNetX Dataworks‐USA: Overview of a Multi‐Purpose, De‐Identified, Federated Electronic Health Record Real‐World Data and Analytics Network and Comparison to the US Ce	7
Adverse drug reaction signal detection methods in spontaneous reporting system: A systematic review	7
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data	7
Issue Information	7
Use of antidepressants and risk of repeat self‐harm in older adults 75+ with nonfatal self‐harm: A 1‐year prospective national study	7
The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A Cross‐Sectional Study	7
Issue Information	7
Sex‐specific incidence of hepatitis B virus flares among Bcr‐Abl tyrosine kinase inhibitor users in Taiwan	7
Dipeptidyl Peptidase‐4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease Requiring Dialysis	7
Validation Assessment of Privacy‐Preserving Synthetic Electronic Health Record Data: Comparison of Original Versus Synthetic Data on Real‐World COVID‐19 Vaccine Effectiveness	7
	7
Corrigendum	7
Opioid Use After Hip Fracture and Subsequent Fracture Outcomes: A Self‐Controlled Case Series Design	7
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual)	6
Preregistration: A Key to Credible Real‐World Evidence Generation	6
Core Concepts in Pharmacoepidemiology: Principled Use of Artificial Intelligence and Machine Learning in Pharmacoepidemiology and Healthcare Research	6
Core Concepts: Self‐Controlled Designs in Pharmacoepidemiology	6
Development and Validation of Claims‐Based Algorithms for Conjunctivitis and Keratitis	6
Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan	6
Sampling in the case‐time‐control design among drug users when outcome prevents further treatment	6
The Effect of Isoniazid for Tuberculosis Prevention on Pregnancy Risk Among Women Living With HIV on Antiretroviral Treatment and Progestin‐Based Hormonal Contraception	6
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data	6
Rescheduling gabapentinoids had negligible effects on prescribing behaviour by general practitioners in England	6
Real‐World Use of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistenc	6
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in ty	6
Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self‐Controlled Case Series Study	6
To wait or not to wait: Weighing the pros and cons of early identification of safety concerns for medications used in pregnancy	6
	6
Mobile apps for quick adverse drug reaction report: A scoping review	6
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events	6
Opioid tapering and mental health crisis in older adults	6
Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020	6
Patterns of filled prescriptions and the association with risk of drug‐induced death. A population‐based nested case‐control register study	6
Signal detection of COVID‐19 vaccines adverse events using spontaneous reports from South Korea	6
Accuracy and validity of reported opioid prescription days' supply	6
Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses	6
	6
Prevalence of self‐medication practices among pregnant women in India: A systematic review and meta‐analysis	5
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors	5
	5
Validation studies of Japanese administrative health care data: A scoping review	5
Correction to “A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data”	5
INSIGHT: A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety	5
Issue Information	5
Overview of global real‐world data sources for pediatric pharmacoepidemiologic research	5
Comparing IPCW Models to Adjust for Informative Censoring During COVID‐19 Using Data From the Clinical Practice Research Datalink	5
Association of Benzodiazepine Prescription With Short‐Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT	5
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials	5
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase	5
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022	5
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain	5
Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study	5

Real world prescription of beta‐blockers in patients with asthma	5
The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark	5
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings	5
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?	5
Real‐world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy	5
Mapping Use of High Dose or Long‐Term Oral Glucocorticoids and Steroid‐Sparing Strategies in Adults With Chronic Conditions: A Rapid Scoping Review of Reviews	5
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis	5
Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy	5
The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures	5
Issue Information	5
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis	5
Validation of ICD‐10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare System	4
Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users	4
Stratified analysis in comparative effectiveness studies that emulate randomized trials	4
Antidepressant Use Trajectories and Risk of Discontinuation After Adolescents and Young Adult Cancer Diagnosis	4
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old	4
Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure	4
Clarifying the causal contrast: An empirical example applying the prevalent new user study design	4
Issue Information	4
Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data	4
Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study	4
Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment	4
Impact on In‐ and Out‐of‐Hospital Drug Prescriptions of Including a More Expensive Me‐Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study	4
Pain‐related hospitalization and emergency room visit following initial analgesic prescription after outpatient surgery	4
Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014–2018)	4
	4
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) Codes	4
Issue Information	4
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies	4
STUDENT ABSTRACTS of ISPE's 2024 Mid‐Year Meeting, Orlando, Florida, USA, 14–16 April 2024	4
Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation	4
The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia	4
Issue Information	4
Evaluating the Impact of Data Standardization on Real‐World Data	4
Correction to “An Open‐Source Implementation of Tree‐Based Scan Statistics”	4
Impact and Effectiveness of COVID ‐19 mRNA Vaccination Against COVID	4
Myopericarditis following COVID‐19 mRNA vaccination	4
Validation of an algorithm for identifying incident cancer cases based on long‐term illness and diagnosis related group program data from the French National Health Insurance Informati	4
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy	4
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case–control study designs	4
Current Use of Common Data Models in the Nordic Countries	4
Where to begin? Thirty must‐read papers for newcomers to pharmacoepidemiology	4
Gout and sodium‐glucose cotransporter‐2 inhibitors	4
A Two‐Step Framework for Validating Causal Effect Estimates	4
Issue Information	4
Validity of claims data for identifying cancer incidence in the Japan public health center‐based prospective study for the next generation	4
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world data	4
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching	4
Development and Application of an Algorithm for Statin‐Induced Myopathy Based on Electronic Health Record‐Derived Structured Elements	4
Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program	4
Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews	3
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach	3
Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA‐2 trial	3
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning	3
Issue Information	3
An algorithm‐based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example	3
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies i	3
Categorization of COVID‐19 severity to determine mortality risk	3
A European, Observational, 3‐Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The POSE	3
Diagnostic Performance of Prostate Cancer Disease‐Specific Phenotypes Identified Using Real‐World Databases: A Systematic Review	3
	3
A Real‐World Study on Adverse Reactions of Belimumab Based on the FDA Adverse Event Reporting System Database	3
Vancomycin‐Induced Acute Kidney Injury in Intensive Care Patients: A Target Trial Emulation Study Using Multicenter Routinely Collected Data	3
Initiation of antidepressant medication in people with type 2 diabetes living in the United Kingdom—A retrospective cohort study	3
Issue Information	3
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis	3
Combining Super Learner with high‐dimensional propensity score to improve confounding adjustment: A real‐world application in chronic lymphocytic leukemia	3
Application of multiple validated algorithms for identifying incident breast cancer among individuals with atopic dermatitis	3
Artificial intelligence in pharmacovigilance: Do we need explainability?	3
Corrigendum to “Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden – a population‐based register study”	3
A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy	3
Validation of an ICD‐10 case‐finding algorithm for endometrial cancer in US insurance claims	3
MetaLAB‐HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records	3
	3
Use of electronic health record data to examine administrations of pro re nata analgesics during hip fracture post‐acute care	3
Development of a multivariate prediction model to identify individual case safety reports which require clinical review	3
Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Pre	3
High‐throughput screening for prescribing cascades among real world statin initiators	3
Design considerations for observational studies of drugs for advanced cancer	3
Oxymorphone and Oxycodone Pharmacy Purchases in US Counties: Prelude to the Largest Rural Human Immunodeficiency Virus Outbreak in US History	3
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post‐marketing surveillance	3
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database	3
Adherence and persistence of HIV pre‐exposure prophylaxis use in the United States	3
ISPE AfRIG Conference—Abstracts for PDS Publication, June 10–14, 2024, Mombasa, Kenya	3
Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi‐stakeholder cross‐sec	3
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe	3
Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI)	3
A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid	3
Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review	3
Antibiotic use in children before, during and after hospitalisation	3
	3
Prescriber Adherence to Antihypertensive Prescription Guidelines and the Impact of Patient Socioeconomic Factors: A Cross‐Sectional Study Using Data From the Irish Longitudinal Study on Ageing	3
Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based	3
Have People Treated With Antihypertensives Been Diagnosed With Hypertension? A Cross‐Sectional Study in Stockholm, Sweden	3
A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelina	3